Skip to Content
About Us Become an Authorised Buyer Medical Partners Blog Contact Us
🌐Ship toSelect country
  1. All products
  2. Shop by Brand
  3. Restylane Eyelight Lidocaine - 1 x 0,5ml
  4. Shop by Brand
Pricelist: Default Pricelist
Pricelist: Default Pricelist
Restylane Eyelight Lidocaine - 1 x 0,5ml

Restylane Eyelight Lidocaine - 1 x 0,5ml

Restylane Eyelight is an FDA-approved hyaluronic acid filler from Galderma built on firm-gel NASHA technology, formulated at 20mg/ml HA with 3mg/ml lidocaine. It is specifically designed for the undereye area, filling infraorbital hollows to reduce dark circles and shadows while helping smooth crow's feet, with clinical trial data showing most patients satisfied with reduced undereye shadowing through 18 months. For use by licensed, trained medical professionals only.

FDA-Approved
56.00 € 56.00 €
  • Brand
Contact Us
Terms and Conditions

Shipping: 
DHL EXPRESS SHIPPING (EU) — approx. 2-3 working days
STANDARD SHIPPING (EU) — approx. 7-10 working days
Select your delivery country in the header to check availability for your destination.
Category Fillers Brand Restylane®
SKU A0210 Share
Treatment Areas EyesTear Troughs
Tags FDA-Approved

Restylane Eyelight is formulated specifically for the tear trough area, built on Galderma's NASHA technology in a lower-viscosity gel suited to the thin skin under the eyes. Formulated with lidocaine for a more comfortable injection experience.

CONCENTRATION

  • Hyaluronic acid (NASHA technology, low viscosity)
  • Lidocaine hydrochloride 0.3%

THE PACK INCLUDES

  • 1 x 0.5ml Syringe

STORAGE CONDITIONS

  • Store between 2°C and 25°C

RESULTS & DURATION

Results typically last 6-9 months, depending on individual metabolism.

INDICATIONS

  • Tear trough hollowing
  • Under-eye volume loss

TREATMENT AREAS

  • Tear troughs
  • Under-eye area

Restylane Eyelight is injected into the deep dermis or supraperiosteal plane beneath the tear trough using fine linear threading or micro-bolus technique.

Results are visible immediately, with final results assessed after 1-2 weeks.

  • Pregnancy or breastfeeding
  • People under the age of 18
  • Active infection or inflammation at the treatment site
  • Known hypersensitivity to hyaluronic acid or lidocaine
  • Patients prone to hypertrophic scarring
  • Autoimmune diseases affecting the skin